Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending artery disease: A 10- year follow-up, single-center, propensity score analysis Umberto Benedetto, MD, PhD, Shahzad G. Raja, MRCS, FRCS(C-Th), Rafik F.B. Soliman, MD, FRCS(C-Th), Alberto Albanese, MD, Anand Jothidasan, MRCS, Charles D. Ilsley, MD, Mohamed Amrani, MD, PhD, FECTS The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 4, Pages 1316-1322 (October 2014) DOI: 10.1016/j.jtcvs.2013.12.062 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Survival curves according to Left, treatment and Right, type of drug-eluting stent implanted. HR, Hazard ratio; DES-PCI, percutaneous coronary intervention with drug-eluting stent; MIDCAB, minimally invasive direct coronary artery bypass; ES, eluting stent; RR, repeat revascularization. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1316-1322DOI: (10.1016/j.jtcvs.2013.12.062) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Probability for late death for minimally invasive direct coronary artery bypass (MIDCAB) versus percutaneous coronary intervention with drug-eluting stents (DES-PCI) stratified by age, diabetes status, and creatinine (crea) > 200 mmol/L. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1316-1322DOI: (10.1016/j.jtcvs.2013.12.062) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions